3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Prostate Cancer -

Few major complications after prostate radiation

Cancer • • Prostate CancerFeb 13, 09

Less than 7 percent of men with prostate cancer who have radiation therapy experience major complications in the first 30 days, new research shows.

Radiation therapy “is quite safe for older patients, although it is associated with a small but measurable increase in short-term major complications,” Dr. Shabbir M. H. Alibhai from University Health Network, Toronto, Ontario, Canada told Reuters Health.

Alibhai and colleagues compared major 30-day complications in men who had radiation therapy or radical prostatectomy (removal of the prostate) for early “organ-confined” prostate cancer.

Despite being older and having more co-existing illnesses, men who received radiation had lower complication rates in each category compared with men who had surgery, the investigators found.

Among the 7,661 men who received radiation, 9 (0.1 percent) died within 30 days. The 30-day mortality rate increased with age (from 0 percent for men younger than 60 years to 0.8 percent for men aged 80 years and older). Among the 11,010 men who had surgery, 53 (0.5 percent) died within 30 days.

Only 6.5 percent of men had at least 1 complication within 30 days of radiation, the researchers note, compared to 30.2 percent of surgery patients.

In the radiation group, complication rates peaked within 30 days and then declined promptly, for every category of complications.

“Our data confirm the belief that most prostate cancer specialists have about the relative safety of (radiation therapy) in older men,” Alibhai concluded. “We recognize this is only one part of a triangle, the other points being long-term efficacy and long-term toxicity (particularly genitourinary, sexual, and gastrointestinal) that must be considered when deciding on an active treatment (i.e., radical prostatectomy or radiation therapy) for early-stage prostate cancer.”

SOURCE: Cancer, January 15, 2009.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site